https://geneonline.news/bio-asia-pacific-2024-close-asean-collaborations-catalyzing-innovation-and-global-partnerships/2024-10-13T20:07:59.000Zweekly0.8 https://geneonline.news/20240913-organon-bao-pharma-sj02/2024-09-26T00:07:52.000Zweekly0.8 https://geneonline.news/20240912-bora-taichung/2024-09-23T17:04:52.000Zweekly0.8 https://geneonline.news/20240912-fraud-tshbiopharm-bora/2024-09-23T17:04:54.000Zweekly0.8 https://geneonline.news/2024-biopharma-industrial-trend-in-oncology-sector/2024-09-23T17:04:55.000Zweekly0.8 https://geneonline.news/esmo-2024-abbvie-msd-astrazeneca-regeneron-bms-daiichi-sankyo/2024-09-23T17:04:56.000Zweekly0.8 https://geneonline.news/rd100-2024-taiwan-best-record-asia-top-one/2024-09-23T17:05:05.000Zweekly0.8 https://geneonline.news/illumina-tso-comprehensive-fda-approval/2024-09-23T17:02:59.000Zweekly0.8 https://geneonline.news/2024-0911-linbioscience-lbs008-stgd1/2024-09-23T17:03:04.000Zweekly0.8 https://geneonline.news/biosecure-act-impact-on-taiwan-biopharma-industry/2024-09-23T17:03:08.000Zweekly0.8 https://geneonline.news/us-biosecure-act-business-collaboration-and-supply-chain-impact/2024-09-23T17:03:13.000Zweekly0.8 https://geneonline.news/20240908-rybrevant-lazcluze-combine-egfr-nsclc-survival-rate-increase/2024-09-17T22:48:53.000Zweekly0.8 https://geneonline.news/202409-msd-keytruda-dme-adc-sclc/2024-09-17T22:48:58.000Zweekly0.8 https://geneonline.news/20240908-astrazeneca-daiichi-sankyo-tropion-lung01-trop2/2024-09-17T22:49:00.000Zweekly0.8 https://geneonline.news/2024-0909-bora-formosa-app13007/2024-09-17T22:49:04.000Zweekly0.8 https://geneonline.news/moderna-covid-19-tfda-2024-0909/2024-09-17T22:19:06.000Zweekly0.8 https://geneonline.news/ai心肌病篩查技術顯著提升產婦健康：最新臨床試驗/2024-09-09T14:08:51.000Zweekly0.8 https://geneonline.news/altrubio-ceo-judy-chou/2024-09-17T22:19:01.000Zweekly0.8 https://geneonline.news/fda-對-ai-在醫療領域的監管-與-醫療器材批准流程/2024-09-09T14:51:59.000Zweekly0.8 https://geneonline.news/強生公司手術機器人交易違規-判賠10億美元震驚醫/2024-09-09T09:33:53.000Zweekly0.8 https://geneonline.news/lotuspharm-sabofi-20240906-alpha-choay-chymotrypsine/2024-09-17T11:56:04.000Zweekly0.8 https://geneonline.news/nhia-icd-dystonia-dbs/2024-09-17T11:56:19.000Zweekly0.8 https://geneonline.news/bioaro-ceo-anmol-kapoor-quantum-computing-of-multi-omics/2024-09-17T16:25:31.000Zweekly0.8 https://geneonline.news/pharmaessentia-ropeg-pv/2024-09-17T11:57:03.000Zweekly0.8 https://geneonline.news/apec-linkou-cgmh/2024-09-17T11:57:08.000Zweekly0.8 https://geneonline.news/中國領先基因工程技術-促神經元生長/2024-09-05T16:46:16.000Zweekly0.8 https://geneonline.news/cupisco-mgt-cup-2024-esmo/2024-09-17T11:57:23.000Zweekly0.8 https://geneonline.news/io-biotech-加強-癌症疫苗-臨床試驗，idmc建議繼續，市場信心/2024-09-05T14:30:55.000Zweekly0.8 https://geneonline.news/奈米治療技術-攻克紅樹林危機-佛羅里達生態系統迎/2024-09-05T14:04:27.000Zweekly0.8 https://geneonline.news/蔗糖素-三氯蔗糖-是什麼-對身體有什麼影響/2025-02-07T16:52:10.000Zweekly0.8 https://geneonline.news/vytrus-biotech-植物外泌體技術創新-引領皮膚與毛髮護理革命/2024-09-06T10:40:30.000Zweekly0.8 https://geneonline.news/biotechusa-與-f-c-barcelona-攜手運動營養領域開創新局面/2024-09-06T10:46:08.000Zweekly0.8 https://geneonline.news/acepodia-pfizer-ignite-immunotherapy/2024-09-17T11:57:52.000Zweekly0.8 https://geneonline.news/2024-apec-medical-forum-medical-technology-assessment/2024-09-17T11:57:31.000Zweekly0.8 https://geneonline.news/pharmaessentia-ropeg-forus-therapeutics/2024-09-12T17:17:21.000Zweekly0.8 https://geneonline.news/stli-2024-webinar3-ai-ml-clinical-trials/2026-01-26T14:05:58.000Zweekly0.8 https://geneonline.news/msd-keytruda-challenge-on-new-indication-pharma-essentia-new-competitor/2024-09-12T17:17:35.000Zweekly0.8 https://geneonline.news/nvidia-2024-q2-financial-report/2024-09-12T17:17:42.000Zweekly0.8 https://geneonline.news/fda-roundup-august-27-2024/2024-09-12T17:17:44.000Zweekly0.8 https://geneonline.news/2024-ers-copd-dupixent-itepekimab/2024-09-12T17:17:48.000Zweekly0.8 https://geneonline.news/2024-btc-summary/2024-09-17T11:57:43.000Zweekly0.8 https://geneonline.news/2024-btc-regulation-adjustment-and-policy-promotion-of-whole-person-health-care-infrastructure/2024-09-12T17:53:22.000Zweekly0.8 https://geneonline.news/2024-btc-continue-to-contribute-to-society-after-retirement-delay-aging-and-reduce-long-term-care/2024-09-09T22:17:39.000Zweekly0.8 https://geneonline.news/2024-btc-great-alliance-of-medical-materials-and-pharmaceuticals-high-level-talents-return-to-taiwan/2024-09-09T22:17:45.000Zweekly0.8 https://geneonline.news/bora-pharmaceuticals-acquires-30-5-of-tanvex-biopharma-and-becomes-the-largest-legal-shareholder/2024-08-30T16:26:22.000Zweekly0.8 https://geneonline.news/2024-btc-complete-the-new-drug-industry-chain-strengthen-continuous-smart-manufacturing-and-enhance-the-international-image-of-taiwans-emerging-medical-industry/2024-09-09T22:17:51.000Zweekly0.8 https://geneonline.news/2024-btc-gene-cell-therapy-outsourcing-center/2024-09-09T22:18:07.000Zweekly0.8 https://geneonline.news/2024-btc-taiwan-ai-university-alliance-standardization-convenience-and-cross-field-smart-medical-care/2024-09-09T22:18:05.000Zweekly0.8 https://geneonline.news/2024-btc-created-in-taiwan-smart-technology-accelerates-cross-domain-innovation-in-biomedicine/2024-09-09T22:19:23.000Zweekly0.8 https://geneonline.news/2024-btc-smart-health-ai/2024-09-09T22:18:15.000Zweekly0.8 https://geneonline.news/computer-aided-drug-discovery-revolution-challenges/2024-09-09T22:18:27.000Zweekly0.8 https://geneonline.news/european-medicines-agency-validates-bristol-myers-squibbs-application-for-car-t-cell-therapy-breyanzi-for-relapsed-or-refractory-follicular-lymphoma/2024-08-22T15:50:02.000Zweekly0.8 https://geneonline.news/artificial-intelligence-ai-accelerates-antibody-design-and-generates-data-to-assist-antibody-design-and-rapid-iterative-optimization/2024-09-09T22:18:30.000Zweekly0.8 https://geneonline.news/health2sync-collaborates-with-sanofi-to-expand-into-the-south-korean-market/2024-08-21T21:45:49.000Zweekly0.8 https://geneonline.news/rybrevant-plus-lazcluze-approved-in-the-u-s-as-a-first-line-chemotherapy-free-nsclc-treatment/2024-09-09T22:18:43.000Zweekly0.8 https://geneonline.news/johnson-johnson-to-acquire-v-wave-2024/2024-09-05T16:39:48.000Zweekly0.8 https://geneonline.news/otezla-apremilast-available-in-the-u-s-for-moderate-to-severe-pediatric-plaque-psoriasis/2024-09-05T16:39:45.000Zweekly0.8 https://geneonline.news/fasenra-approved-in-china-for-the-treatment-of-severe-eosinophilic-asthma/2024-09-05T16:39:45.000Zweekly0.8 https://geneonline.news/tirzepatide-reduced-the-risk-of-developing-type-2-diabetes-by-94-in-adults-with-pre-diabetes-and-obesity-or-overweight/2024-09-05T16:39:50.000Zweekly0.8 https://geneonline.news/bora-completes-acquisition-of-us-sterile-fill-finish-facility-from-emergent/2024-09-05T16:40:02.000Zweekly0.8 https://geneonline.news/astrazeneca-daiichi-sankyo-enhertu-breakthrough-therapy-designation-ema-validation/2024-09-05T16:40:04.000Zweekly0.8 https://geneonline.news/gsk-b7-h3-adc-us-fda-breakthrough-therapy-designation/2024-09-05T16:39:26.000Zweekly0.8 https://geneonline.news/2024-h2-obesity-clinical-trials/2024-09-12T17:53:19.000Zweekly0.8 https://geneonline.news/biotech-financing-darkest-before-the-dawn/2024-09-05T16:40:13.000Zweekly0.8 https://geneonline.news/2024-q2-financial-report-az-gsk/2024-09-09T14:57:13.000Zweekly0.8 https://geneonline.news/fda-roundup-august-16-2024/2024-09-05T16:40:15.000Zweekly0.8 https://geneonline.news/stli-2024-webinar2-nucleic-acid-drugs/2026-01-26T14:05:44.000Zweekly0.8 https://geneonline.news/taiwan-advance-bio-pharmaceutical-spinal-cord-injury/2024-08-16T15:21:40.000Zweekly0.8 https://geneonline.news/incyte-and-syndax-announce-u-s-fda-approval-of-niktimvo-axatilimab-csfr-for-the-treatment-of-chronic-graft-versus-host-disease/2024-08-28T11:22:28.000Zweekly0.8 https://geneonline.news/u-s-government-announces-final-prices-for-first-10-medicare-part-d-drugs-marking-completion-of-historic-drug-price-negotiations/2024-09-12T17:53:17.000Zweekly0.8 https://geneonline.news/fda-rejects-ecstasy-as-a-therapeutic-drug-whats-next-for-psychedelic-therapy/2024-08-28T11:21:58.000Zweekly0.8 https://geneonline.news/astrazenecas-two-major-therapies-approved-in-the-us-and-europe-offering-new-opportunities-for-endometrial-cancer-and-small-cell-lung-cancer-treatments/2024-08-28T11:22:03.000Zweekly0.8 https://geneonline.news/gileads-livdelzi-seladelpar-granted-accelerated-approval-for-primary-biliary-cholangitis-by-u-s-fda/2024-08-28T11:22:08.000Zweekly0.8 https://geneonline.news/moderna-and-coursera-launch-free-course-on-mrna-technology/2024-08-15T14:09:01.000Zweekly0.8 https://geneonline.news/alzheimers-disease-cellular-resilience-wtchen-interview/2026-01-26T14:06:10.000Zweekly0.8 https://geneonline.news/illumina-announces-strategy-to-accelerate-value-creation/2024-08-28T11:22:15.000Zweekly0.8 https://geneonline.news/leqembi-lecanemab-approved-for-the-treatment-of-alzheimers-disease-in-the-united-arab-emirates/2024-08-28T11:22:21.000Zweekly0.8 https://geneonline.news/neuronal-substance-p-drives-metastasis-through-an-extracellular-rnatlr7-axis/2024-08-28T11:21:34.000Zweekly0.8 https://geneonline.news/enhertu-approved-in-china-for-patients-with-previously-treated-her2-positive-advanced-or-metastatic-gastric-cancer/2024-08-22T11:27:34.000Zweekly0.8 https://geneonline.news/lilly-opens-state-of-the-art-research-and-development-center-in-the-boston-seaport/2024-08-22T11:27:40.000Zweekly0.8 https://geneonline.news/formosa-pharmaceuticals-listed-on-the-taiwan-stock-exchange/2024-08-22T11:27:42.000Zweekly0.8 https://geneonline.news/oneness-biotech-fespixon-indonesian-approval/2024-08-22T11:27:44.000Zweekly0.8 https://geneonline.news/blood-test-uses-protein-clock-to-predict-risk-of-alzheimers-and-other-diseases/2024-08-19T14:34:13.000Zweekly0.8 https://geneonline.news/merck-to-acquire-investigational-b-cell-depletion-therapy-cn201-from-curon-biopharmaceutical/2024-08-19T14:34:03.000Zweekly0.8 https://geneonline.news/fda-approves-first-nasal-spray-for-treatment-of-anaphylaxis/2024-08-21T16:05:04.000Zweekly0.8 https://geneonline.news/2024-q2-financial-report-bayer-gilead-illumina-beigene/2024-08-19T16:38:25.000Zweekly0.8 https://geneonline.news/serviers-1-8-billion-acquisition-pays-off-fda-approves-first-in-class-treatment-for-two-types-of-rare-brain-cancer/2024-08-09T18:11:14.000Zweekly0.8 https://geneonline.news/novartis-receives-fda-accelerated-approval-for-fabhalta-iptacopan-the-first-and-only-complement-inhibitor-for-the-reduction-of-proteinuria-in-primary-iga-nephropathy-igan/2024-08-09T17:20:35.000Zweekly0.8 https://geneonline.news/2024-q2-financial-report-elililly-novonordisk-amgen-biontech-zoetis/2024-08-19T14:33:33.000Zweekly0.8 https://geneonline.news/2024-us-top-10-biocluster/2024-08-19T14:33:18.000Zweekly0.8 https://geneonline.news/delivering-affordable-biologic-medicines-worldwide-an-interview-with-tanvex-chairman-and-ceo-henry-chen/2024-08-19T14:29:48.000Zweekly0.8 https://geneonline.news/2024-q2-financial-report-moderna_teva_abbott_biogen_thermofisher/2024-08-19T14:30:41.000Zweekly0.8 https://geneonline.news/2024-q2-financial-report-pfizer-vertex-regeneron-bms-merck/2024-08-19T14:30:46.000Zweekly0.8 https://geneonline.news/healthy-ageing-tech-show-2024-closing/2024-08-19T14:31:32.000Zweekly0.8 https://geneonline.news/2024-q2-financial-report-jj-abbvie-msd-roche-novartis/2024-08-19T14:31:16.000Zweekly0.8 https://geneonline.news/nycu-healthy-ageing-tech-forum/2024-08-14T14:17:45.000Zweekly0.8 https://geneonline.news/healthy-ageing-tech-show-2024-opening/2024-08-14T14:17:41.000Zweekly0.8 https://geneonline.news/bio-asia-taiwan-2024-review/2024-08-14T14:17:36.000Zweekly0.8 https://geneonline.news/bio-asia-taiwan-2024-digital-health/2024-08-14T14:17:31.000Zweekly0.8 https://geneonline.news/bio-asia-taiwan-2024-biosimilar-conference/2024-08-14T14:14:24.000Zweekly0.8